RN7SL546P

Across TCGA pan-cancer cohorts, RN7SL546P RNA is linked to patient survival in 20 of 34 cancer types, making it the most broadly survival-associated RN7SL546P data layer.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher RN7SL546P RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated RN7SL546P expression acts as an unfavorable survival marker, although some lineages such as LUAD and BLCA show a favorable association.

LUAD, BLCA, and KIRC are the cancer types where RN7SL546P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	DFS	Median	All	0.768	0.586	<.001	67	view →
BLCA	OS	Median	All	0.702	0.561	.002	64	view →
KIRC	OS	Tertile	All	0.729	0.842	<.001	58	view →
SKCM	DFS	Tertile	III,IV	0.428	0.185	.002	47	view →
SARC	OS	Quartile	All	0.317	0.550	.003	29	view →
CESC	OS	Median	All	0.909	0.840	.018	28	view →
MESO	OS	Tertile	IV	0.850	0.253	.002	27	view →
COAD	OS	Quartile	All	0.828	0.466	<.001	19	view →
ACC	OS	Tertile	IV	0.327	0.633	.045	18	view →
UCEC	OS	Quartile	All	0.890	0.941	.008	18	view →
READ	OS	Quartile	II,III,IV	0.478	0.796	.003	12	view →
LIHC	OS	Quartile	All	0.684	0.815	.010	12	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 20 lineages.

RN7SL546P–LUAD (DFS)

Open the LUAD breakdown →